CN103645310B - A kind of Macrodantin chemiluminescence detection kit - Google Patents

A kind of Macrodantin chemiluminescence detection kit Download PDF

Info

Publication number
CN103645310B
CN103645310B CN201310578405.9A CN201310578405A CN103645310B CN 103645310 B CN103645310 B CN 103645310B CN 201310578405 A CN201310578405 A CN 201310578405A CN 103645310 B CN103645310 B CN 103645310B
Authority
CN
China
Prior art keywords
furadantin
solution
horseradish peroxidase
liquid
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310578405.9A
Other languages
Chinese (zh)
Other versions
CN103645310A (en
Inventor
王善普
李秀梅
耿玉静
李权伟
张和平
高进勇
李志彦
李胜利
刘海强
周小双
沈成蕊
张志鹏
张鹏翼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Bairui Biotechnology Co., Ltd.
LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD.
Original Assignee
LUOYANG LAIPSON INFORMATION TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LUOYANG LAIPSON INFORMATION TECHNOLOGY Co Ltd filed Critical LUOYANG LAIPSON INFORMATION TECHNOLOGY Co Ltd
Priority to CN201310578405.9A priority Critical patent/CN103645310B/en
Publication of CN103645310A publication Critical patent/CN103645310A/en
Application granted granted Critical
Publication of CN103645310B publication Critical patent/CN103645310B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76Chemiluminescence; Bioluminescence
    • G01N21/763Bioluminescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a kind of detection Macrodantin chemiluminescence detection kit, comprise concentrated washing lotion, negative controls, positive reference substance, chemical luminescence for liquid, furadantin standard substance, the furadantin specific antibody of horseradish peroxidase-labeled and wrapped by the luminescent screen of furadantin; The furadantin specific antibody of described horseradish peroxidase-labeled is, horseradish peroxidase-labeled taking furadantin-BSA as the anti-furadantin polyclonal antibody of immunogen immune new zealand white rabbit gained; The furadantin specific antibody of horseradish peroxidase-labeled is prepared with Over-voltage protection; The present invention detects that Macrodantin chemiluminescence detection kit is highly sensitive, sensing range width, easy and simple to handle fast and nontoxic pollution-free; Metabolite and the carrier conjugation of furadantin is adopted to prepare envelope antigen, more economical; The preparation of horseradish peroxidase marker, adopts single stage method, and method easy steps is more simple, is beneficial to suitability for industrialized production.

Description

A kind of Macrodantin chemiluminescence detection kit
Technical field
The present invention relates to a kind of test kit, specifically a kind of Macrodantin chemiluminescence detection kit.
Background technology
In detection feed, the technology of microbiotic mainly contains following several method at present:
(1) Physico-chemical tests method
After the nineties in 20th century, most Physico-chemical tests method measuring furadantin mainly relies on liquid chromatography technology to be separated, next is look/mass spectrometric hyphenated technique, the detection method such as vapor-phase chromatography, high performance thin-layer chromatography, because of its distinctive performance separately, slightly apply in antibiotics leftover detection. Drug residue in chromatography detection feed will through sample preparation (comprising the steps such as the extraction of sample, deproteinated, centrifugal, chromatography column purification, derivatize), the separation of medicine and the detection of medicine. Physico-chemical tests method utilizes special reaction or character that the group in antibiotic molecule has to measure its content, can carry out qualitative and quantitative analysis and drug identification, can be used as the confirmation method of fodder antibiotics detection. This method detection sensitivity is higher, but instrument and testing cost height, trace routine complicated, more consuming time between etc.
(2) immune analysis method
Immune analysis method is the analytical procedure based on the specificity of antigen and antibody, reversibility association reaction, and current drug residue immuno analytical method mainly divides three major types: the method for relatively independent analytical procedure, immuno analytical method and conventional physical and chemical analysis technology coupling, immunity receptor method. Dutch vanweeman, schurrs in 1973 and Sweden Engvall, Perlmann propose enzyme-linked immunosorbent assay respectively, and over more than 30 year, microbiotic in immunological method detection food has been carried out big quantity research by Chinese scholars. But owing to microbiotic is haptens, antigen constructing technology difficulty is big, immunologic opsonin is strong, testing cost height, the companies such as current IDEXX are to exempt from the research in analytical method comparatively ripe, and this technology domestic is still in researchdevelopment. Current mainly with enzyme linked immunosorbent assay, radioimmunoassay luminescence method, fluorescent immune method, chemoluminescence method etc.; The methods such as enzyme linked immunosorbent assay, radioimmunoassay luminescence method, fluorescent immune method compare with luminous phase chemistry luminescence method, and it is lower that its enzyme exempts from sensitivity.
Summary of the invention
The present invention seeks to the deficiency for solving the problems of the technologies described above, it is provided that a kind of Macrodantin chemiluminescence detection kit, it has highly sensitive, sensing range width, the advantage such as fast easy and simple to handle.
The present invention solves the problems of the technologies described above the technical scheme adopted to be: a kind of Macrodantin chemiluminescence detection kit, comprises concentrated washing lotion, negative controls, positive reference substance, chemical luminescence for liquid, furadantin standard substance, the furadantin specific antibody of horseradish peroxidase-labeled and has wrapped by the luminescent screen of furadantin;
Described concentrated washing lotion is: containing the phosphate buffered saline buffer of Tween-20 and sodium-chlor;
Described negative controls is: the furadantin after more than the 5 parts Sterile Filtrations deposited separately is detected as negative pig urine mixture;
Described positive reference substance is: the pig urine mixture of the furadantin test positive after more than the 5 parts Sterile Filtrations deposited separately;
Described chemical luminescence for liquid, comprises A liquid and B liquid; A liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds luminol,3-aminophthalic acid cyclic hydrazide and sodium tetraphenylborate in this damping fluid, mixes and can obtain A liquid; B liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds 0.1%H in this damping fluid by weight2O2Mix and can obtain B liquid;
Described furadantin standard substance are the diluent that concentration is respectively 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml, 8.1ng/ml furadantin;
The furadantin specific antibody of described horseradish peroxidase-labeled is, horseradish peroxidase-labeled taking furadantin-BSA as the anti-furadantin polyclonal antibody of immunogen immune new zealand white rabbit gained; Prepare the furadantin specific antibody of horseradish peroxidase-labeled with Over-voltage protection, reaction system is: first with the NaIO of the horseradish peroxidase solution of 1ml concentration 5mg/ml and 0.15ml concentration 0.1mol/L4Solution mix even after, it is placed in 4 DEG C of lucifuges 0.5 hour, then the ethylene glycol adding 0.25ml shakes even room temperature lucifuge 1 hour, then 4 DEG C of dialysed overnight it are placed in, afterwards with 0.2ml concentration 0.2mol/L, pH value is the carbonate bag of 9.6 is 9.2-9.5 by solution by the hydroformylation horseradish peroxidase solution adjust pH that obtains after dialysis, anti-for 5mg furadantin polyclonal antibody is dissolved in 1.0ml concentration 0.01mol/L, add immediately after the coating buffer of pH9.6 in the horseradish peroxidase solution after above-mentioned hydroformylation and react 1 hour in 37 DEG C, then add the NaBH of 0.1ml concentration 3.5mg/ml4Solution, mixed even places 2 hours in 4 DEG C, and >=1:1000 colourless or be with brown clarified liq of after carrying out purifying with gel permeation chromatography, selecting to tire, is the furadantin specific antibody of horseradish peroxidase-labeled;
The preparation method of described furadantin-BSA immunogen is:
Prepared by step one, immunogen:
Step one, claim 10mg para-amino benzoic acid to dissolve in 1.1mL0.2mol/LHCl, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain para-amino benzoic acid solution; Then the NaNO of 6mg is taken2It is dissolved in the distilled water of 0.35mL, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain NaNO2Solution; By NaNO2Dropwise joins in para-amino benzoic acid solution, and lucifuge reacts 1 hour, obtains mixed solution A;
Step 2, the furadantin taking 0.3-1.2mg are dissolved in 10mL containing in the borate buffer solution of NaCl, are stirred to and dissolve completely, obtain mixing solutions B at being placed in 0-4 DEG C; Dropwise joining in mixing solutions B by above-mentioned steps gained mixed solution A, lucifuge reacts 2 hours, obtains orange solution C;
In the described borate buffer solution containing NaCl, the concentration of borax is 0.05mol/L, and pH value is 8.5, and is the NaCl of 0.15mol/L containing concentration;
Step 3, in orange solution C, add H3BO3Crystal regulates its pH value to 7.4, then adds 94mg bovine serum albumin, 80mg carbodiimide and 4mgN-N-Hydroxysuccinimide, is then placed in stirring at room temperature 2 hours, obtains orange solution D;
Step 4, above-mentioned steps gained orange solution D is transferred in dialysis tubing, it is the PBS of 7.4 with 0.01mol/L, pH, dialyse five days at 0-4 DEG C, within every 12 hours, change a PBS; By the solution freeze-drying after dialysis, obtain faint yellow solid powder and it is immunogen furadantin-BSA, be placed on-20 DEG C of preservations, for subsequent use.
Described wrapping by the preparation method of the luminescent screen of furadantin is:
Step one, furadantin and ovalbumin carried out coupling obtain envelope antigen:
(1) NaNO of 9mg is taken2It is dissolved in the distilled water of 0.3mL, obtains NaNO2Solution; Taking 10mg furadantin is dissolved in the hydrochloric acid of 1.6mL0.2mol/L, and 0-4 DEG C is stirred to and dissolves completely, obtains furadantin solution; Then by gained NaNO2Dropwise adds in gained furadantin solution, and lucifuge reacts 0.5 hour;
(2), after reaction terminates, adding 25mg amine sulfate until releasing without nitrogen, namely obtaining diazotizing furadantin solution;
(3) claiming 70mg ovalbumin to be dissolved in the 0.1mol/L of 4mL, pH value is in the PBS phosphate buffer solution of 7.5, obtains ovalbumin solution; Then the diazotizing furadantin dropwise described in above-mentioned steps is joined in ovalbumin solution, obtain mixing solutions E; Then with the sodium hydroxide of 1mol/L by the pH of mixing solutions E to being adjusted to 7.5, at being then placed in 0-4 DEG C, lucifuge reacts 18 hours;
(4) transferring in dialysis tubing by reacted for above-mentioned steps lucifuge reaction solution, with 0.01mol/L, pH value is the PBS of 7.4, dialyses five days at 0-4 DEG C, within every 12 hours, changes a PBS; Then by centrifugal for dialyzate 3000 revs/min 15 minutes, freeze-drying supernatant liquor, obtains faint yellow solid powder and is envelope antigen furadantin-OVA, be placed on-20 DEG C of preservations, for subsequent use;
Step 2, bag quilt:
(1) with 0.05mol/L, pH value be 9.6 carbonate bag by solution, envelope antigen is made into the solution of 1.5 �� g/mL, and the �� L that adds 100 in the reacting hole of each polystyrene board, spend the night at 4 DEG C afterwards, abandon solution in hole next day, wash 3 times with lavation buffer solution, each 5 minutes;
(2) close the above-mentioned polystyrene board having wrapped quilt by lock solution, 250 �� L/ holes, 37 DEG C hatch 1 hour after washing, obtain wrapping by the luminescent screen of furadantin.
A detection method for Macrodantin chemiluminescence detection kit, its concrete detecting step is:
Step one, add sample: by the furadantin standard solution of each concentration and sample solution, joining with the add-on in 50 �� L/ holes wraps by the reacting hole of the luminescent screen of furadantin, then every hole adds 100 �� L employing coating buffers with the furadantin specific antibody of the horseradish peroxidase-labeled of 1:7000 dilution proportion, then hatches 0.5 hour for 37 DEG C;
Step 2, washing: inclining to and wrap by liquid in the hole of the luminescent screen of furadantin, every hole adds washing soln 250 �� L, washs 3 times, pats dry;
Step 3, add luminous substrate liquid: after the A liquid of luminous substrate and B liquid are mixed mixture, add 100 �� L luminous substrate liquid mixtures wrapping every hole in the luminescent screen by furadantin,
Step 4, detection: the luminous intensity measuring every hole with chemical illumination immunity analysis instrument;
Step 5, result judge: get standard substance log concentration and do X-coordinate, and standard substance detection luminous value logarithm does ordinate zou, does typical curve, and the concentration of each sample can be calculated from typical curve.
Useful effect is:
1, Macrodantin chemiluminescence detection kit of the present invention, highly sensitive, sensing range width, easy and simple to handle fast, nontoxic pollution-free, optical signal time length length and instrument used simple, the chemiluminescence detection kit of economic detection furadantin, provide its preparation method simultaneously, and detect the method for furadantin microbiotic in sample. The chemical luminescence ELISA detection kit of antibiotics leftover detection have highly sensitive, easy fast, accurately, security is good and the feature of usage period length, comparing with traditional colorimetric ELISA method, analytical procedure is easy fast, sensitivity can improve an order of magnitude. Play a significant role in being expected in feed Nitrofurantoin residue and detecting.
2, Macrodantin chemiluminescence detection kit of the present invention adopts the metabolite of furadantin and carrier conjugation to prepare envelope antigen, and more economical, step is more simple, is beneficial to suitability for industrialized production; The preparation of horseradish peroxidase marker, adopts single stage method, and method is simple, is more suitable for suitability for industrialized production, and obtains good effect through verification experimental verification.
Accompanying drawing explanation
Fig. 1 is the process flow sheet that the present invention prepares Macrodantin chemiluminescence detection kit;
Fig. 2 is the result standard graphic representation of embodiments of the invention detection;
Embodiment
A kind of Macrodantin chemiluminescence detection kit, comprises concentrated washing lotion, negative controls, positive reference substance, chemical luminescence for liquid, furadantin standard substance, the furadantin specific antibody of horseradish peroxidase-labeled and has wrapped by the luminescent screen of furadantin; Concrete preparation process is as shown in fig. 1;
Described concentrated washing lotion is: containing the phosphate buffered saline buffer of Tween-20 and sodium-chlor;
Described negative controls is: the furadantin after more than the 5 parts Sterile Filtrations deposited separately is detected as negative pig urine mixture;
Described positive reference substance is: the pig urine mixture of the furadantin test positive after more than the 5 parts Sterile Filtrations deposited separately;
Described chemical luminescence for liquid, comprises A liquid and B liquid; A liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds luminol,3-aminophthalic acid cyclic hydrazide and sodium tetraphenylborate in this damping fluid, mixes and can obtain A liquid; B liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds 0.1%H in this damping fluid by weight2O2Mix and can obtain B liquid;
Described furadantin standard substance are the diluent that concentration is respectively 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml, 8.1ng/ml furadantin;
The preparation method of the furadantin specific antibody of described horseradish peroxidase-labeled is:
Prepared by step one, immunogen:
(1) claim 10mg para-amino benzoic acid to dissolve in 1.1mL0.2mol/LHCl, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain para-amino benzoic acid solution; Then the NaNO of 6mg is taken2It is dissolved in the distilled water of 0.35mL, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain NaNO2Solution; By NaNO2Dropwise joins in para-amino benzoic acid solution, and lucifuge reacts 1 hour, obtains mixed solution A;
(2) furadantin taking 0.3-1.2mg is dissolved in 10mL containing in the borate buffer solution of NaCl, is stirred to and dissolves completely, obtain mixing solutions B at being placed in 0-4 DEG C; Dropwise joining in mixing solutions B by above-mentioned steps gained mixed solution A, lucifuge reacts 2 hours, obtains orange solution C;
In the described borate buffer solution containing NaCl, the concentration of borax is 0.05mol/L, and pH value is 8.5, and is the NaCl of 0.15mol/L containing concentration;
(3) in orange solution C, H is added3BO3Crystal regulates its pH value to 7.4, then adds 94mg bovine serum albumin, 80mg carbodiimide and 4mgN-N-Hydroxysuccinimide, is then placed in stirring at room temperature 2 hours, obtains orange solution D;
(4) above-mentioned steps gained orange solution D is transferred in dialysis tubing, it is the PBS of 7.4 with 0.01mol/L, pH, dialyse five days at 0-4 DEG C, within every 12 hours, change a dialyzate; By the solution freeze-drying after dialysis, obtain faint yellow solid powder and it is immunogen furadantin-BSA, be placed on-20 DEG C of preservations, for subsequent use.
Step 2, employing new zealand white rabbit are as immune animal, taking furadantin-BSA as immunogen, first immunisation dosage is 100 �� g/ rabbit, during first immunisation, immunogen is dissolved in and makes emulsifying agent into isopyknic physiological saline and Freund's complete adjuvant, nape portion multi-point injection, booster immunization dosage reduces by half in isopyknic physiological saline and Freund's incomplete adjuvant mixing and emulsifying, first immunisation and second immunisation interval 14 days, later every immunity in 2 weeks once immunity five times altogether, do not add adjuvant for the last time; Last immunity Culling heart blood after 7 days, centrifugal obtains anti-furadantin polyclonal antibody.
The preparation of step 3, horseradish peroxidase marker
Preparing enzyme labelling furadantin antibody with Over-voltage protection, reaction system is: first with the NaIO of the horseradish peroxidase solution of 1ml concentration 5mg/ml and 0.15ml concentration 0.1mol/L4Solution mix even after, it is placed in 4 DEG C of lucifuges 0.5 hour, then the ethylene glycol adding 0.25ml shakes even room temperature lucifuge 1 hour, then 4 DEG C of dialysed overnight it are placed in, afterwards with 0.2ml concentration 0.2mol/L, pH value is the carbonate bag of 9.6 is 9.2-9.5 by solution by the hydroformylation horseradish peroxidase solution adjust pH that obtains after dialysis, anti-for 5mg furadantin polyclonal antibody is dissolved in 1.0ml concentration 0.01mol/L, add immediately after the coating buffer of pH9.6 in the horseradish peroxidase solution after above-mentioned hydroformylation and react 1 hour in 37 DEG C, then add the NaBH of 0.1ml concentration 3.5mg/ml4Solution, mixed even places 2 hours in 4 DEG C, and >=1:1000 colourless or be with brown clarified liq of after carrying out purifying with gel permeation chromatography, selecting to tire, is the furadantin specific antibody of horseradish peroxidase-labeled;
Described wrapping by the preparation method of the luminescent screen of furadantin is:
Step one, furadantin and ovalbumin carried out coupling obtain envelope antigen:
(1) NaNO of 9mg is taken2It is dissolved in the distilled water of 0.3mL, obtains NaNO2Solution; Taking 10mg furadantin is dissolved in the hydrochloric acid of 1.6mL0.2mol/L, and 0-4 DEG C is stirred to and dissolves completely, obtains furadantin solution; Then by gained NaNO2Dropwise adds in gained furadantin solution, and lucifuge reacts 0.5 hour;
(2), after reaction terminates, adding 25mg amine sulfate until releasing without nitrogen, namely obtaining diazotizing furadantin solution;
(3) claiming 70mg ovalbumin to be dissolved in the 0.1mol/L of 4mL, pH value is in the PBS phosphate buffer solution of 7.5, obtains ovalbumin solution; Then the diazotizing furadantin dropwise described in above-mentioned steps is joined in ovalbumin solution, obtain mixing solutions E; Then with the sodium hydroxide of 1mol/L by the pH of mixing solutions E to being adjusted to 7.5, at being then placed in 0-4 DEG C, lucifuge reacts 18 hours;
(4) transferring in dialysis tubing by reacted for above-mentioned steps lucifuge reaction solution, with 0.01mol/L, pH value is the PBS of 7.4, dialyses five days at 0-4 DEG C, within every 12 hours, changes a PBS; Then by centrifugal for dialyzate 3000 revs/min 15 minutes, freeze-drying supernatant liquor, obtains faint yellow solid powder and is envelope antigen furadantin-OVA, be placed on-20 DEG C of preservations, for subsequent use;
Step 2, bag quilt:
(1) with 0.05mol/L, pH value be 9.6 carbonate bag by solution, envelope antigen is made into the solution of 1.5 �� g/mL, and the �� L that adds 100 in the reacting hole of each polystyrene board, spend the night at 4 DEG C afterwards, abandon solution in hole next day, wash 3 times with lavation buffer solution, each 5 minutes;
(2) close the above-mentioned polystyrene board having wrapped quilt by lock solution, 250 �� L/ holes, 37 DEG C hatch 1 hour after washing, obtain wrapping by the luminescent screen of furadantin.
A detection method for Macrodantin chemiluminescence detection kit, its concrete detecting step is:
Step one, add sample: joined with the add-on in 50 �� L/ holes by the furadantin standard solution of each concentration and wrap by the reacting hole of the luminescent screen of furadantin, then every hole adds 100 �� L employing coating buffers with the furadantin specific antibody of the horseradish peroxidase-labeled of 1:7000 dilution proportion, then hatches 0.5 hour for 37 DEG C;
Step 2, washing: inclining to and wrap by liquid in the hole of the luminescent screen of furadantin, every hole adds washing soln 250 �� L, washs 3 times, pats dry;
Step 3, add luminous substrate liquid: after the A liquid of luminous substrate and B liquid are mixed mixture, add 100 �� L luminous substrate liquid mixtures wrapping every hole in the luminescent screen by furadantin,
Step 4, detection: the luminous intensity measuring every hole with chemical illumination immunity analysis instrument;
Step 5, result judge: get standard substance log concentration and do X-coordinate, and standard substance detection luminous value logarithm does ordinate zou, does typical curve, and the concentration of each sample can be calculated from typical curve.
Embodiment
A kind of Macrodantin chemiluminescence detection kit, comprises concentrated washing lotion, negative controls, positive reference substance, chemical luminescence for liquid, furadantin standard substance, the furadantin specific antibody of horseradish peroxidase-labeled and has wrapped by the luminescent screen of furadantin;
Described concentrated washing lotion is: containing the phosphate buffered saline buffer of Tween-20 and sodium-chlor;
Described negative controls is: the furadantin after more than the 5 parts Sterile Filtrations deposited separately is detected as negative pig urine mixture;
Described positive reference substance is: the pig urine mixture of the furadantin test positive after more than the 5 parts Sterile Filtrations deposited separately;
Described chemical luminescence for liquid, comprises A liquid and B liquid; A liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds luminol,3-aminophthalic acid cyclic hydrazide and sodium tetraphenylborate in this damping fluid, mixes and can obtain A liquid; B liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds 0.1%H in this damping fluid by weight2O2Mix and can obtain B liquid;
Described furadantin standard substance are the diluent that concentration is respectively 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml, 8.1ng/ml furadantin;
The preparation method of the furadantin specific antibody of described horseradish peroxidase-labeled is:
Prepared by step one, immunogen:
(1) claim 10mg para-amino benzoic acid to dissolve in 1.1mL0.2mol/LHCl, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain para-amino benzoic acid solution; Then the NaNO of 6mg is taken2It is dissolved in the distilled water of 0.35mL, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain NaNO2Solution; By NaNO2Dropwise joins in para-amino benzoic acid solution, and lucifuge reacts 1 hour, obtains mixed solution A;
(2) furadantin taking 0.3-1.2mg is dissolved in 10mL containing in the borate buffer solution of NaCl, is stirred to and dissolves completely, obtain mixing solutions B at being placed in 0-4 DEG C; Dropwise joining in mixing solutions B by above-mentioned steps gained mixed solution A, lucifuge reacts 2 hours, obtains orange solution C;
In the described borate buffer solution containing NaCl, the concentration of borax is 0.05mol/L, and pH value is 8.5, and is the NaCl of 0.15mol/L containing concentration;
(3) in orange solution C, H is added3BO3Crystal regulates its pH value to 7.4, then adds 94mg bovine serum albumin, 80mg carbodiimide and 4mgN-N-Hydroxysuccinimide, is then placed in stirring at room temperature 2 hours, obtains orange solution D;
(4) above-mentioned steps gained orange solution D is transferred in dialysis tubing, it is the PBS of 7.4 with 0.01mol/L, pH, dialyse five days at 0-4 DEG C, within every 12 hours, change a dialyzate; By the solution freeze-drying after dialysis, obtain faint yellow solid powder and it is immunogen furadantin-BSA, be placed on-20 DEG C of preservations, for subsequent use.
Step 2, employing new zealand white rabbit are as immune animal, taking furadantin-BSA as immunogen, first immunisation dosage is 100 �� g/ rabbit, during first immunisation, immunogen is dissolved in and makes emulsifying agent into isopyknic physiological saline and Freund's complete adjuvant, nape portion multi-point injection, booster immunization dosage reduces by half in isopyknic physiological saline and Freund's incomplete adjuvant mixing and emulsifying, first immunisation and second immunisation interval 14 days, later every immunity in 2 weeks once immunity five times altogether, do not add adjuvant for the last time; Last immunity Culling heart blood after 7 days, centrifugal obtains anti-furadantin polyclonal antibody.
The preparation of step 3, horseradish peroxidase marker
Preparing enzyme labelling furadantin antibody with Over-voltage protection, reaction system is: first with the NaIO of the horseradish peroxidase solution of 1ml concentration 5mg/ml and 0.15ml concentration 0.1mol/L4Solution mix even after, it is placed in 4 DEG C of lucifuges 0.5 hour, then the ethylene glycol adding 0.25ml shakes even room temperature lucifuge 1 hour, then 4 DEG C of dialysed overnight it are placed in, afterwards with 0.2ml concentration 0.2mol/L, pH value is the carbonate bag of 9.6 is 9.2-9.5 by solution by the hydroformylation horseradish peroxidase solution adjust pH that obtains after dialysis, anti-for 5mg furadantin polyclonal antibody is dissolved in 1.0ml concentration 0.01mol/L, add immediately after the coating buffer of pH9.6 in the horseradish peroxidase solution after above-mentioned hydroformylation and react 1 hour in 37 DEG C, then add the NaBH of 0.1ml concentration 3.5mg/ml4Solution, mixed even places 2 hours in 4 DEG C, and >=1:1000 colourless or be with brown clarified liq of after carrying out purifying with gel permeation chromatography, selecting to tire, is the furadantin specific antibody of horseradish peroxidase-labeled;
Described wrapping by the preparation method of the luminescent screen of furadantin is:
Step one, furadantin and ovalbumin carried out coupling obtain envelope antigen:
(1) NaNO of 9mg is taken2It is dissolved in the distilled water of 0.3mL, obtains NaNO2Solution; Taking 10mg furadantin is dissolved in the hydrochloric acid of 1.6mL0.2mol/L, and 0-4 DEG C is stirred to and dissolves completely, obtains furadantin solution; Then by gained NaNO2Dropwise adds in gained furadantin solution, and lucifuge reacts 0.5 hour;
(2), after reaction terminates, adding 25mg amine sulfate until releasing without nitrogen, namely obtaining diazotizing furadantin solution;
(3) claiming 70mg ovalbumin to be dissolved in the 0.1mol/L of 4mL, pH value is in the PBS phosphate buffer solution of 7.5, obtains ovalbumin solution; Then the diazotizing furadantin dropwise described in above-mentioned steps is joined in ovalbumin solution, obtain mixing solutions E; Then with the sodium hydroxide of 1mol/L by the pH of mixing solutions E to being adjusted to 7.5, at being then placed in 0-4 DEG C, lucifuge reacts 18 hours;
(4) transferring in dialysis tubing by reacted for above-mentioned steps lucifuge reaction solution, with 0.01mol/L, pH value is the PBS of 7.4, dialyses five days at 0-4 DEG C, within every 12 hours, changes a PBS; Then by centrifugal for dialyzate 3000 revs/min 15 minutes, freeze-drying supernatant liquor, obtains faint yellow solid powder and is envelope antigen furadantin-OVA, be placed on-20 DEG C of preservations, for subsequent use;
Step 2, bag quilt:
(1) with 0.05mol/L, pH value be 9.6 carbonate bag by solution, envelope antigen is made into the solution of 1.5 �� g/mL, and the �� L that adds 100 in the reacting hole of each polystyrene board, spend the night at 4 DEG C afterwards, abandon solution in hole next day, wash 3 times with lavation buffer solution, each 5 minutes;
(2) close the above-mentioned polystyrene board having wrapped quilt by lock solution, 250 �� L/ holes, 37 DEG C hatch 1 hour after washing, obtain wrapping by the luminescent screen of furadantin.
The concrete detecting step of a kind of Macrodantin chemiluminescence detection kit:
Step one, sample pre-treatments
Feed pre-treating process: take 1.0 �� 0.05g feed sample; Adding 5ml deionized water, fully vibration is to dissolving; Take out 50ul supernatant and it is used as analysis.
Step 2, detecting step
(1) sample is added: Cistofuran metabolite series standard strength solution and the sample solution adding 50uL/ hole in luminescent screen, then Cistofuran metabolite antibody working fluid 50uL/ hole is added, add diluted fresh horseradish peroxidase-furadantin antibody (1:7000) 100 �� L/ hole, 37 DEG C 0.5 hour;
(2) wash: incline the middle liquid that portals, and adds the washings in 300uL/ hole in luminescent screen, pat dry after leaving standstill 5min, repeat three times;
(3) luminescent solution is added: every hole adds luminescent solution lOOuL;
(4) result judges: gets standard substance log concentration and does X-coordinate, and standard substance detection luminous value logarithm does ordinate zou, does typical curve, and result is such as Fig. 2, figure standard curve y=-1.0354x+4.7213, R2=0.9983; The concentration of each sample can be calculated from typical curve, and result is such as table 1.
Table 1:
Furadantin standard substance (ng/ml) Luminous value
0.1 550000
0.3 183000
0.9 60000
2.7 21000
8.1 5500
24.3 1800

Claims (1)

1. a Macrodantin chemiluminescence detection kit, it is characterised in that: comprise concentrated washing lotion, negative controls, positive reference substance, chemical luminescence for liquid, furadantin standard substance, the furadantin specific antibody of horseradish peroxidase-labeled and wrapped by the luminescent screen of furadantin;
Described concentrated washing lotion is: containing the phosphate buffered saline buffer of Tween-20 and sodium-chlor;
Described negative controls is: the furadantin after more than the 5 parts Sterile Filtrations deposited separately is detected as negative pig urine mixture;
Described positive reference substance is: the pig urine mixture of the furadantin test positive after more than the 5 parts Sterile Filtrations deposited separately;
Described chemical luminescence for liquid, comprises A liquid and B liquid; A liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds luminol,3-aminophthalic acid cyclic hydrazide and sodium tetraphenylborate in this damping fluid, mixes and can obtain A liquid; B liquid making method is: the Tris-HCl damping fluid first configuring 0.2mol/LpH7.8, adds 0.1%H in this damping fluid by weight2O2Mix and can obtain B liquid;
Described furadantin standard substance are the diluent that concentration is respectively 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml, 8.1ng/ml furadantin;
The furadantin specific antibody of described horseradish peroxidase-labeled is, horseradish peroxidase-labeled taking furadantin-BSA as the anti-furadantin polyclonal antibody of immunogen immune new zealand white rabbit gained; Prepare the furadantin specific antibody of horseradish peroxidase-labeled with Over-voltage protection, reaction system is: first with the NaIO of the horseradish peroxidase solution of 1ml concentration 5mg/ml and 0.15ml concentration 0.1mol/L4Solution mix even after, it is placed in 4 DEG C of lucifuges 0.5 hour, then the ethylene glycol adding 0.25ml shakes even room temperature lucifuge 1 hour, then 4 DEG C of dialysed overnight it are placed in, afterwards with 0.2ml concentration 0.2mol/L, pH value is the carbonate bag of 9.6 is 9.2-9.5 by solution by the hydroformylation horseradish peroxidase solution adjust pH that obtains after dialysis, anti-for 5mg furadantin polyclonal antibody is dissolved in 1.0ml concentration 0.01mol/L, the carbonate bag of pH9.6 is reacted 1 hour in 37 DEG C in the horseradish peroxidase solution after above-mentioned hydroformylation by adding immediately after solution, then the NaBH of 0.1ml concentration 3.5mg/ml is added4Solution, mixed even places 2 hours in 4 DEG C, and >=1:1000 colourless or be with brown clarified liq of after carrying out purifying with gel permeation chromatography, selecting to tire, is the furadantin specific antibody of horseradish peroxidase-labeled;
The preparation method of the furadantin specific antibody of described horseradish peroxidase-labeled is:
Prepared by step one, immunogen:
(1) claim 10mg para-amino benzoic acid to dissolve in 1.1mL0.2mol/LHCl, it is placed in 0-4 DEG C and is stirred to and dissolves completely, obtain para-amino benzoic acid solution; Then the NaNO2 taking 6mg is dissolved in the distilled water of 0.35mL, is placed in 0-4 DEG C and is stirred to and dissolves completely, obtains NaNO2 solution; Being joined by NaNO2 dropwise in para-amino benzoic acid solution, lucifuge reacts 1 hour, obtains mixed solution A;
(2) furadantin taking 0.3-1.2mg is dissolved in 10mL containing in the borate buffer solution of NaCl, is stirred to and dissolves completely, obtain mixing solutions B at being placed in 0-4 DEG C; Dropwise joining in mixing solutions B by above-mentioned steps gained mixed solution A, lucifuge reacts 2 hours, obtains orange solution C;
In the described borate buffer solution containing NaCl, the concentration of borax is 0.05mol/L, and pH value is 8.5, and is the NaCl of 0.15mol/L containing concentration;
(3) in orange solution C, add H3BO3 crystal and regulate its pH value to 7.4, then add 94mg bovine serum albumin, 80mg carbodiimide and 4mgN-N-Hydroxysuccinimide, be then placed in stirring at room temperature 2 hours, obtain orange solution D;
(4) above-mentioned steps gained orange solution D is transferred in dialysis tubing, it is the PBS of 7.4 with 0.01mol/L, pH, dialyse five days at 0-4 DEG C, within every 12 hours, change a dialyzate; By the solution freeze-drying after dialysis, obtain faint yellow solid powder and it is immunogen furadantin-BSA, be placed on-20 DEG C of preservations, for subsequent use;
Step 2, employing new zealand white rabbit are as immune animal, taking furadantin-BSA as immunogen, first immunisation dosage is 100 �� g/ rabbit, during first immunisation, immunogen is dissolved in isopyknic physiological saline and Freund's complete adjuvant makes emulsifying agent, nape portion multi-point injection, booster immunization dosage reduces by half in isopyknic physiological saline and Freund's incomplete adjuvant mixing and emulsifying, first immunisation and second immunisation interval 14 days, later every immunity in 2 weeks once immunity five times altogether, do not add adjuvant for the last time; Last immunity Culling heart blood after 7 days, centrifugal obtains anti-furadantin polyclonal antibody;
Described wrapping by the preparation method of the luminescent screen of furadantin is:
Step one, furadantin and ovalbumin carried out coupling obtain envelope antigen:
(1) NaNO of 9mg is taken2It is dissolved in the distilled water of 0.3mL, obtains NaNO2Solution; Taking 10mg furadantin is dissolved in the hydrochloric acid of 1.6mL0.2mol/L, and 0-4 DEG C is stirred to and dissolves completely, obtains furadantin solution; Then by gained NaNO2Dropwise adds in gained furadantin solution, and lucifuge reacts 0.5 hour;
(2), after reaction terminates, adding 25mg amine sulfate until releasing without nitrogen, namely obtaining diazotizing furadantin solution;
(3) claiming 70mg ovalbumin to be dissolved in the 0.1mol/L of 4mL, pH value is in the PBS phosphate buffer solution of 7.5, obtains ovalbumin solution; Then the diazotizing furadantin dropwise described in above-mentioned steps is joined in ovalbumin solution, obtain mixing solutions E; Then with the sodium hydroxide of 1mol/L by the pH of mixing solutions E to being adjusted to 7.5, at being then placed in 0-4 DEG C, lucifuge reacts 18 hours;
(4) transferring in dialysis tubing by reacted for above-mentioned steps lucifuge reaction solution, with 0.01mol/L, pH value is the PBS of 7.4, dialyses five days at 0-4 DEG C, within every 12 hours, changes a PBS; Then by centrifugal for dialyzate 3000 revs/min 15 minutes, freeze-drying supernatant liquor, obtains faint yellow solid powder and is envelope antigen furadantin-OVA, be placed on-20 DEG C of preservations, for subsequent use;
Step 2, bag quilt:
(1) with 0.05mol/L, pH value be 9.6 carbonate bag by solution, envelope antigen is made into the solution of 1.5 �� g/mL, and the �� L that adds 100 in the reacting hole of each polystyrene board, spend the night at 4 DEG C afterwards, abandon solution in hole next day, wash 3 times with lavation buffer solution, each 5 minutes;
(2) close the above-mentioned polystyrene board having wrapped quilt by lock solution, 250 �� L/ holes, 37 DEG C hatch 1 hour after washing, obtain wrapping by the luminescent screen of furadantin;
The method of prepared Macrodantin chemiluminescence detection kit detection Nitrofurantoin residue, its concrete detecting step is:
Step one, add sample: by the furadantin standard solution of each concentration and sample solution, joining with the add-on in 50 �� L/ holes wraps by the reacting hole of the luminescent screen of furadantin, then every hole adds 100 �� L employing coating buffers with the furadantin specific antibody of the horseradish peroxidase-labeled of 1:7000 dilution proportion, then hatches 0.5 hour for 37 DEG C;
Step 2, washing: inclining to and wrap by liquid in the hole of the luminescent screen of furadantin, every hole adds washing soln 250 �� L, washs 3 times, pats dry;
Step 3, add luminous substrate liquid: after the A liquid of luminous substrate and B liquid are mixed mixture, add 100 �� L luminous substrate liquid mixtures wrapping every hole in the luminescent screen by furadantin,
Step 4, detection: the luminous intensity measuring every hole with chemical illumination immunity analysis instrument;
Step 5, result judge: get standard substance log concentration and do X-coordinate, and standard substance detection luminous value logarithm does ordinate zou, does typical curve, and the concentration of each sample can be calculated from typical curve.
CN201310578405.9A 2013-11-18 2013-11-18 A kind of Macrodantin chemiluminescence detection kit Active CN103645310B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310578405.9A CN103645310B (en) 2013-11-18 2013-11-18 A kind of Macrodantin chemiluminescence detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310578405.9A CN103645310B (en) 2013-11-18 2013-11-18 A kind of Macrodantin chemiluminescence detection kit

Publications (2)

Publication Number Publication Date
CN103645310A CN103645310A (en) 2014-03-19
CN103645310B true CN103645310B (en) 2016-06-01

Family

ID=50250561

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310578405.9A Active CN103645310B (en) 2013-11-18 2013-11-18 A kind of Macrodantin chemiluminescence detection kit

Country Status (1)

Country Link
CN (1) CN103645310B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104215765A (en) * 2014-09-13 2014-12-17 佛山市质量计量监督检测中心 Preparation of immunizing antigen and envelope antigen for detecting nitrofurantoin metabolites
CN104849475A (en) * 2015-05-02 2015-08-19 王贤俊 Quantified detection method for luteinizing hormone (LH)
CN104897909A (en) * 2015-05-02 2015-09-09 王贤俊 Luteinizing hormone (LH)chemiluminescence immunoassay quantitative determination kit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101393212A (en) * 2008-11-04 2009-03-25 山东大学 Chemiluminescence ELISA detection kit of furadantin
CN101597330A (en) * 2009-06-26 2009-12-09 青岛康地恩药业有限公司 The synthetic method of a kind of Ractopamine hydrochloride artificial antigen
CN102565032A (en) * 2010-12-15 2012-07-11 北京勤邦生物技术有限公司 Magnetic granule chemiluminescence kit for detecting nitrofurantoin metabolite and application of magnetic granule chemiluminescence kit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101307303B (en) * 2007-05-16 2010-10-13 哈尔滨仁皇药业股份有限公司 Kit for detecting clenobuterol hydrochloride residue and method for preparing same
CN101368961B (en) * 2008-04-02 2012-11-14 北京科美生物技术有限公司 Chemical luminescence immune analysis quantitative measuring reagent kit for urine bladder cancer antigen and preparation method thereof
CN101738473B (en) * 2008-11-13 2013-06-05 威海威高生物科技有限公司 Treponema pallidum antibody diagnostic kit and preparation method thereof
CN101446589A (en) * 2008-12-29 2009-06-03 山东大学 Chemiluminescent enzyme-linked immunosorbent assay (CELISA) kit for detecting salbutamol
CN102539414A (en) * 2010-12-16 2012-07-04 北京勤邦生物技术有限公司 Magnetic particle chemiluminescence kit for detecting nitrofurantion and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101393212A (en) * 2008-11-04 2009-03-25 山东大学 Chemiluminescence ELISA detection kit of furadantin
CN101597330A (en) * 2009-06-26 2009-12-09 青岛康地恩药业有限公司 The synthetic method of a kind of Ractopamine hydrochloride artificial antigen
CN102565032A (en) * 2010-12-15 2012-07-11 北京勤邦生物技术有限公司 Magnetic granule chemiluminescence kit for detecting nitrofurantoin metabolite and application of magnetic granule chemiluminescence kit

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Development of an enzyme-linked immunosorbent assay for the detection of nitrofurantoin metabolite,1-amino-hydantoin,in animal tissue;Wenxiao Jiang,et al.;《Food Control》;20120131;第23卷(第1期);第20-25页 *
动物饲料中呋喃唑酮的酶联免疫吸附检测研究;张会彩 等;《"2008年京津冀畜牧兽医科技创新交流会暨新思想、新观点、新方法论坛"论文集》;20100312;第159-163页 *
呋喃妥因残留代谢物人工抗原的合成与鉴定;宋宁宁 等;《中国动物传染病学报》;20121231;第20卷(第3期);第55-61页 *

Also Published As

Publication number Publication date
CN103645310A (en) 2014-03-19

Similar Documents

Publication Publication Date Title
CA1206899A (en) Specific binding assays utilizing analyte-cytolsin conjugates
AU2007257105B8 (en) Elisa kit for detecting Sudan red and method thereof
CN106645692B (en) Estriol homogeneous enzyme immunoassay detection reagent, preparation method and detection method
CN108508215A (en) A kind of time-resolved fluoroimmunoassay chromatograph test strip and its preparation method and application of detection tetracycline medication
CN109298177A (en) Time-resolved fluorescence immunoassay method based on Magneto separate
CN101776685B (en) Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof
CN101571539A (en) Elisa kit for detecting cephalo-type medicine and application thereof
CN101231291A (en) Kit and method for quantitative determination of Fumonisin B1 content in food by ELISA detection technique
CN108535486A (en) A kind of chloramphenicol immunofluorescence assay method based on europium label
CN101799469A (en) Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof
CN103645310B (en) A kind of Macrodantin chemiluminescence detection kit
CN102206270B (en) Saxitoxin artificial antigen and anti-saxitoxin antibody, their preparation methods and application
CN102288765A (en) Immunofluorescence chloramphenicol detecting method based on quantum dots and special kit
CN101871936A (en) Rhodamine B ELISA detection method
CN110095596A (en) Chemiluminescence based on Fe-MOFs-fluorescence double-bang firecracker answers immunosensor
CN102079789A (en) Method for detecting maduramicin and special enzyme-linked immunoassay reagent kit thereof
CN101299045B (en) Method for detecting florfenicol and florfenicol amine and special-purpose enzyme-linked immunologic reagent kit thereof
CN103421072A (en) Dexamethasone semi-antigen, preparation method and applications thereof
CN108802393A (en) A kind of test strips and its preparation method and application method of detection tetrahydro-cannabinolic acid
CN102288763A (en) Immunofluorescence method and special kit for detecting ractopamine based on quantum dots
CN105399639A (en) Tyramine artificial antigen and antibody, and preparation methods and application thereof
CN102565399B (en) Method for detecting hydrocortisone and special enzyme-linked immunosorbent assay kit thereof
CN109298178A (en) Cardiac myosin binding protein C(cMyBP-C based on immunomagnetic beads) time-resolved fluoroimmunoassay kit
CN102262157B (en) Quantum dot-based method for immunofluorescence of clenbuterol hydrochloride and special kit thereby
CN101769919A (en) Immuno-chromatography detection device and detection method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Wang Shanpu

Inventor after: Zhou Xiaoshuang

Inventor after: Shen Chengrui

Inventor after: Zhang Zhipeng

Inventor after: Zhang Pengyi

Inventor after: Li Xiumei

Inventor after: Geng Yujing

Inventor after: Li Quanwei

Inventor after: Zhang Heping

Inventor after: Gao Jinyong

Inventor after: Li Zhiyan

Inventor after: Li Shengli

Inventor after: Liu Haiqiang

Inventor before: Wang Shanpu

Inventor before: Liu Panpan

Inventor before: Wang Huihui

Inventor before: Wang Yudong

Inventor before: Wu Tingcai

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant
PP01 Preservation of patent right

Effective date of registration: 20160822

Granted publication date: 20160601

RINS Preservation of patent right or utility model and its discharge
PD01 Discharge of preservation of patent

Date of cancellation: 20170116

Granted publication date: 20160601

RINS Preservation of patent right or utility model and its discharge
TR01 Transfer of patent right

Effective date of registration: 20190111

Address after: 110000 Youth Street 173-2, Shenhe District, Shenyang City, Liaoning Province, 1-22-9

Co-patentee after: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD.

Patentee after: Liaoning Bairui Biotechnology Co., Ltd.

Address before: 471000 West N3 Peony Avenue, Luolong Science Park, Luoyang City, Henan Province

Patentee before: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD.

TR01 Transfer of patent right